MergerJun 1, 2026, 06:12 AM
Lisata: Kuva Labs Delays Tender Offer Commencement
AI Summary
Lisata Therapeutics, Inc. announced that Kuva Labs Inc. will not commence its tender offer for Lisata's outstanding common stock on June 1, 2026, as previously disclosed and agreed upon. This delay comes despite a recent amendment to their merger agreement, which had extended the offer commencement date to June 1. Kuva Labs informed Lisata that it is negotiating with potential financing sources and evaluating the timing, with no assurance provided on if or when the offer will begin.
Key Highlights
- Kuva Labs Inc. will not commence the tender offer for Lisata Therapeutics on June 1, 2026, as previously agreed.
- The original Agreement and Plan of Merger was dated March 6, 2026.
- An amendment on May 29, 2026, had extended the tender offer commencement date to June 1, 2026.
- Kuva Labs is currently negotiating with its potential financing sources.
- There is no assurance as to when, or if, the tender offer will commence.
Price Impact
More from LSTA